Fine Particle Pollution, Alanine Transaminase, and Liver Cancer: A Taiwanese Prospective Cohort Study (REVEAL-HBV)

Journal of the National Cancer Institute

Volumn 108, Issue 3, 2016, Pages

  Pan, Wen Chi ^a,d   Wu, Chih Da ^b,f,g   Chen, Mu Jean ^a,h   Huang, Yen Tsung ^b,c   Chen, Chien Jen ^i,j   Su, Huey Jen ^a   Yang, Hwai I ^e,i  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b Department of Epidemiology ^*  (United States)

^c BROWN UNIVERSITY   (United States)

^d Institute of Environmental and Occupational Health Sciences   (United States)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

^f NATIONAL CHIAYI UNIVERSITY   (Taiwan)

^g HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^h NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

ⁱ GENOMICS RESEARCH CENTER   (Taiwan)

^j NATIONAL TAIWAN UNIVERSITY   (Taiwan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AIR POLLUTANT; PARTICULATE MATTER;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; ENVIRONMENTAL EXPOSURE; FEMALE; FOLLOW UP; GEOGRAPHIC PATHOLOGY; HUMAN; INCIDENCE; INFLAMMATION; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PARTICULATE MATTER; POLLUTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL ANALYSIS; TAIWAN; ADVERSE EFFECTS; AIR POLLUTANT; BLOOD; CARCINOMA, HEPATOCELLULAR; CHRONIC HEPATITIS B; CHRONIC HEPATITIS C; COMPLICATION; ENZYMOLOGY; LIVER NEOPLASMS; METABOLISM; MORTALITY; ODDS RATIO; PARTICLE SIZE; PROPORTIONAL HAZARDS MODEL; REGISTER; RISK; VIROLOGY;

ADULT; AGED; AIR POLLUTANTS; ALANINE TRANSAMINASE; CARCINOMA, HEPATOCELLULAR; CONFOUNDING FACTORS (EPIDEMIOLOGY); ENVIRONMENTAL EXPOSURE; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; MIDDLE AGED; ODDS RATIO; PARTICLE SIZE; PARTICULATE MATTER; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REGISTRIES; RISK; TAIWAN;

EID: 84962617062     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djv341     Document Type: Article

References (47)

1. Miller KA, Siscovick DS, Sheppard L, et al. Long-term exposure to air pollution and incidence of cardiovascular events in women. N Engl J Med. 2007;356(5):447-458.
2. Madrigano J, Kloog I, Goldberg R, et al. Long-term exposure to PM2.5 and incidence of acute myocardial infarction. Environ Health Perspect. 2013;121(2):192-196.
3. Brook RD, Rajagopalan S, Pope CA, 3rd, et al. Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation. 2010;121(21):2331-2378.
4. Raaschou-Nielsen O, Andersen ZJ, Beelen R, et al. Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE). Lancet Oncol. 2013;14(9):813-822.
5. Laden F, Schwartz J, Speizer FE, et al. Reduction in fine particulate air pollution and mortality: Extended follow-up of the Harvard Six Cities study. Am J Respir Crit Care Med. 2006;173(6):667-672.
6. Turner MC, Krewski D, Pope CA, 3rd, et al. Long-term ambient fine particulate matter air pollution and lung cancer in a large cohort of never-smokers. Am J Respir Crit Care Med. 2011;184(12):1374-1381.
7. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224-2260.
8. IARC. IARC monographs on the evaluation of carcinogenic risks to humans: Outdoor air pollution In. Lyon, France: International Agency for Research on Cancer; In press.
9. Huttunen K, Siponen T, Salonen I, et al. Low-level exposure to ambient particulate matter is associated with systemic inflammation in ischemic heart disease patients. Environ Res. 2012;116:44-51.
10. Delfino RJ, Staimer N, Tjoa T, et al. Associations of primary and secondary organic aerosols with airway and systemic inflammation in an elderly panel cohort. Epidemiology. 2010;21(6):892-902.
11. Hoffmann B, Moebus S, Dragano N, et al. Chronic residential exposure to particulate matter air pollution and systemic inflammatory markers. Environ Health Perspect. 2009;117(8):1302-1308.
12. Delfino RJ, Staimer N, Tjoa T, et al. Circulating biomarkers of inflammation, antioxidant activity, and platelet activation are associated with primary combustion aerosols in subjects with coronary artery disease. Environ Health Perspect. 2008;116(7):898-906.
13. O'Neill MS, Veves A, Sarnat JA, et al. Air pollution and inflammation in type 2 diabetes: a mechanism for susceptibility. Occup Environ Med. 2007;64(6):373-379.
14. Zeka A, Sullivan JR, Vokonas PS, et al. Inflammatory markers and particulate air pollution: characterizing the pathway to disease. Int J Epidemiol. 2006;35(5):1347-1354.
15. Hajat A, Allison M, Diez-Roux AV, et al. Long-term exposure to air pollution and markers of inflammation, coagulation, and endothelial activation: a repeat-measures analysis in the Multi-Ethnic Study of Atherosclerosis (MESA). Epidemiology. 2015;26(3):310-320.
16. Wilson DW, Aung HH, Lame MW, et al. Exposure of mice to concentrated ambient particulate matter results in platelet and systemic cytokine activation. Inhal Toxicol. 2010;22(4):267-276.
17. Markevych I, Wolf K, Hampel R, et al. Air pollution and liver enzymes. Epidemiology. 2013;24(6):934-935.
18. Chen CL, Yang HI, Yang WS, et al. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology. 2008;135(1):111-121.
19. Loomba R, Liu J, Yang HI, et al. Synergistic effects of family history of hepatocellular carcinoma and hepatitis B virus infection on risk for incident hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2013;11(12):1636-1645 e1-e3.
20. Iloeje UH, Yang HI, Jen CL, et al. Risk and predictors of mortality associated with chronic hepatitis B infection. Clin Gastroenterol Hepatol. 2007;5(8):921-931.
21. Lee MH, Yang HI, Jen CL, et al. Community and personal risk factors for hepatitis C virus infection: a survey of 23,820 residents in Taiwan in 1991-2. Gut. 2011;60(5):688-694.
22. Liao D, Peuquet DJ, Duan Y, et al. GIS approaches for the estimation of residential-level ambient PM concentrations. Environ Health Perspect. 2006;114(9):1374-1380.
23. Yang HI, Lu SN, Liaw YF, et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med. 2002;347(3):168-174.
24. Huang YT, Jen CL, Yang HI, et al. Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C. J Clin Oncol. 2011;29(27):3643-3650.
25. Vanderweele TJ, Vansteelandt S. Odds ratios for mediation analysis for a dichotomous outcome. Am J Epidemiol. 2010;172(12):1339-1348.
26. VanderWeele TJ. Causal mediation analysis with survival data. Epidemiology. 2011;22(4):582-585.
27. VanderWeele TJ, Asomaning K, Tchetgen Tchetgen EJ, et al. Genetic variants on 15q25.1, smoking, and lung cancer: an assessment of mediation and interaction. Am J Epidemiol. 2012;175(10):1013-1020.
28. Liu Y, Aryee MJ, Padyukov L, et al. Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis. Nat Biotechnol. 2013;31(2):142-147.
29. Song Y, Huang YT, Song Y, et al. Birthweight, mediating biomarkers and the development of type 2 diabetes later in life: a prospective study of multiethnic women. Diabetologia. 2015;58(6):1220-1230.
30. Huang YT, Pan WC. Hypothesis Test of Mediation Effect in Causal Mediation Model with High-dimensional Continuous Mediators. Biometrics. 2015; In press.
31. Park EY, Lim MK, Oh JK, et al. Independent and supra-additive effects of alcohol consumption, cigarette smoking, and metabolic syndrome on the elevation of serum liver enzyme levels. PLoS One. 2013;8(5):e63439.
32. Whitehead TP, Robinson D, Allaway SL. The effects of cigarette smoking and alcohol consumption on serum liver enzyme activities: a dose-related study in men. Ann Clin Biochem. 1996;33 (Pt 6):530-535.
33. Kokaze A, Yoshida M, Ishikawa M, et al. NADH dehydrogenase subunit-2 237 Leu/Met polymorphism modifies effects of cigarette smoking on risk of elevated levels of serum liver enzyme in male Japanese health check-up examinees: a cross-sectional study. Tob Induc Dis. 2014;12(1):11.
34. Wang CS, Wang ST, Chang TT, et al. Smoking and alanine aminotransferase levels in hepatitis C virus infection: implications for prevention of hepatitis C virus progression. Arch Intern Med. 2002;162(7):811-815.
35. Aleksandrova K, Boeing H, Nothlings U, et al. Inflammatory and metabolic biomarkers and risk of liver and bilary tract cancer. Hepatology. 2014;60(3):858-871.
36. Seino Y, Miki T, Kiyonari H, et al. Isx participates in the maintenance of vitamin A metabolism by regulation of beta-carotene 15,15'-monooxygenase (Bcmo1) expression. J Biol Chem. 2008;283(8):4905-4911.
37. Hsu SH, Wang LT, Lee KT, et al. Proinflammatory homeobox gene, ISX, regulates tumor growth and survival in hepatocellular carcinoma. Cancer Res. 2013;73(2):508-518.
38. Grivennikov S, Karin E, Terzic J, et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell. 2009;15(2):103-113.
39. Bromberg J, Wang TC. Inflammation and cancer: IL-6 and STAT3 complete the link. Cancer Cell. 2009;15(2):79-80.
40. Bollrath J, Phesse TJ, von Burstin VA, et al. gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitisassociated tumorigenesis. Cancer Cell. 2009;15(2):91-102.
41. Schwartz J, Coull B, Laden F, et al. The effect of dose and timing of dose on the association between airborne particles and survival. Environ Health Perspect. 2008;116(1):64-69.
42. Atkinson RW, Kang S, Anderson HR, et al. Epidemiological time series studies of PM2.5 and daily mortality and hospital admissions: a systematic review and meta-analysis. Thorax. 2014; In press.
43. Dockery DW, Pope CA, 3rd, Xu X, et al. An association between air pollution and mortality in six U.S. cities. N Engl J Med. 1993;329(24):1753-1759.
44. Pope CA, 3rd, Thun MJ, Namboodiri MM, et al. Particulate air pollution as a predictor of mortality in a prospective study of U.S. adults. Am J Respir Crit Care Med. 1995;151(3 Pt 1):669-674.
45. Samet JM, Dominici F, Curriero FC, et al. Fine particulate air pollution and mortality in 20 U.S. cities, 1987-1994. N Engl J Med. 2000;343(24):1742-1749.
46. Shebl FM, Capo-Ramos DE, Graubard BI, et al. Socioeconomic status and hepatocellular carcinoma in the United States. Cancer Epidemiol Biomarkers Prev. 2012;21(8):1330-1335.
47. Chang ET, Yang J, Alfaro-Velcamp T, et al. Disparities in liver cancer incidence by nativity, acculturation, and socioeconomic status in California Hispanics and Asians. Cancer Epidemiol Biomarkers Prev. 2010;19(12):3106-3118.